Valbiotis SA (8JD) AI Stock Analysis

Valbiotis SA

(Frankfurt:8JD)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Nutrition-health product focusValbiotis operates in the nutrition-health intersection, targeting prevention and support for cardiometabolic conditions. Its focus on plant-based or bioactive formulations and clinical evaluation provides a defined platform for developing products that may address expanding health and prevention needs.

Negative Factors

Persistent unprofitabilityThe scale of the 2025 net loss relative to revenue shows that Valbiotis remains far from operating profitability. Continued losses can consume capital, constrain investment choices, and make the business dependent on future commercial progress or additional financing to sustain development.

Valbiotis SA (8JD) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 22.31M
Dividend Yield: ―
Average Volume (3M): 3,608
Price to Earnings (P/E): -2.1
Beta (1Y): -0.17
Revenue Growth: 183.47%
EPS Growth: 57.15%
Country: Germany
Employees: 50
Sector: Consumer Defensive
Sector Strength: 62
Industry: Biotechnology

Valbiotis SA Business Overview & Revenue Model

Company Description

Valbiotis SA is a French company, established in 2014 and headquartered in Périgny, that specializes in the research and development of nutritional health products. Its primary focus is on preventing and managing metabolic and cardiovascular diseases...

Valbiotis SA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (62)

Financial Indicators

DE:8JD against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	62Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
FR:ALPAT	60Neutral	EUR 4.04M	6.98	―	―	-40.95%	-39.70%
FR:IVA	46Neutral	EUR 760.35M	-6.00	-1625.48%	―	-99.64%	68.67%
FR:POXEL	46Neutral	EUR 8.87M	-0.43	33.88%	―	―	―
FR:GNFT	44Neutral	EUR 541.90M	-5.32	279.22%	―	27.70%	-162.89%
FR:ALGAE	43Neutral	EUR 46.73M	-4.49	-32.62%	―	3.22%	24.05%

* Consumer Defensive Sector Average

Performance Comparison

DE:8JD and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:8JD	Valbiotis SA	0.61	-0.03	-3.96%
FR:GNFT	Genfit SA	10.86	7.31	205.92%
FR:IVA	Inventiva SA	3.18	-0.34	-9.66%
FR:POXEL	Poxel SA	0.17	-0.17	-50.30%
FR:ALGAE	Fermentalg SA	0.39	-0.09	-19.59%
FR:ALPAT	Plant Advanced Technologies SA	3.56	-4.94	-58.12%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Valbiotis SA AI Stock Analysis